Clinical Trials Browser

Phase 2 × Melanoma × Radiation Dose Hypofractionation × Clear all

NCT02819843 2025-01-29

A Study of T-VEC (Talimogene Laherparepvec) With or Without Radiotherapy for Melanoma, Merkel Cell Carcinoma, or Other Solid Tumors

Phase 2 Completed

19 enrolled 7 charts

Melanoma, Carcinoma, Merkel Cell